Top news stories from AMA Morning Rounds®: Week of Nov. 16, 2026

| 5 Min Read

Read AMA Morning Rounds®’ most popular stories in medicine and public health from the week of Nov. 16, 2026–Nov. 20, 2026.

Podcast lean promo icon
On the go? Listen with the podcast instead.

CMS delays Medicaid work rule enforcement for six months

The Washington Post (11/13, Wu) reports, “States set to implement a controversial work requirement for some Medicaid recipients in January may delay enforcement of the rule for six months, the Centers for Medicare and Medicaid Services announced Friday” in a statement from Deputy Administrator and Director of the Center for Medicaid and CHIP Services Dan Brillman.

The New York Times (11/13, Kliff, Sanger-Katz) reports that in a letter to state Medicaid directors, Brillman “acknowledged the significant burden states faced in building out new, expensive software systems to track the employment of enrollees.” Brillman “added that the federal government still expected states in January to begin checking whether Medicaid enrollees are working. But for six months, they will not be required to cancel coverage for people who fail to comply.”

Politico (11/13, Ollstein, Cohen) reports, “The delay is optional, however, and states that want to move forward and begin disenrolling people who can’t prove they meet the requirement or qualify for an exception may still do so.”

You also may be interested in: CMS releases medical frailty work-requirement guidance for Medicaid.

More pregnant women and newborns have been infected with measles in the U.S. in the past two years

The New York Times (11/16, Rosenbluth) reports, “More than 100 pregnant women and at least 13 newborns have been infected with measles in the United States in the past two years, scientists at the Centers for Disease Control and Prevention reported on Monday.” This “new study, a preliminary analysis published in” NEJM Evidence, “is the first to document how measles infections during pregnancy, once extraordinarily rare, have picked up since the highly contagious virus has resurged across the country.” Additionally, the study “offers a clearer picture of how devastating those infections can be,” finding “that nearly one-quarter of the 112 pregnant women infected with measles were hospitalized for complications unrelated to labor, such as pneumonia and respiratory failure.”

U.S. formally loses its status as a country that has eliminated measles

Membership Moves Medicine™

  • Thousands of free CME opportunities to fulfill state requirements
  • A powerful voice fighting for you during uncertain times
  • Research, resources, events and more from the largest physician organization

The Washington Post (11/17, Sun) reports that the U.S. has “formally lost its status as a country that has eliminated measles,” as “the Pan American Health Organization” (PAHO) “announced Tuesday that epidemiological and laboratory evidence showed measles had spread uninterrupted in the U.S. and Mexico for at least 12 months. Combined with Canada’s loss of its measles-elimination status last year, the change means sustained transmission of the most contagious virus to humans has now returned across North America.” 

The New York Times (11/17, Rosenbluth) reports. “State health officials have reported more than 7,700 cases of measles, including 10 deaths, since the resurgence first kicked off … in Texas in January 2025.” While measles cases occurred in the U.S. “between 2000 and 2025, there were fewer than 200 cases most years, and many of them tied to international travel.” 

The AP (11/17, Stobbe, Shastri) reports, “Health officials estimate the measles vaccine prevented 6.2 million deaths in the Americas between 2000 and 2023. Now, the entirety of North America faces the task of earning back the designation.”

Editor’s note: Resurgence of measles across the U.S. has caused preventable hospitalizations and deaths and reflects the consequences of growing gaps in community protection. Read the AMA’s full statement on the loss of measles elimination status.

Genetic variations impact patient experience with chronic pain

The New York Times (11/17, Nunn) reports a study published in Nature Neuroscience sheds new light on common chronic pain, a condition that “can be notoriously difficult to measure, explain or treat.”  In the analysis, which was “the largest of its kind to date” researchers “pooled genetic and health records from more than 1.2 million people across three large biobanks with the aim of mapping the condition’s genetic architecture.” Investigators found that “thousands of tiny genetic variations interact with environmental factors and one another to influence a patient’s experience.” The large-scale “data set in the new study allowed scientists to identify 343 different locations on the human genome that were tied to chronic pain, about a quarter of which had not been identified before. It also helped them map how the affected genes play out in the body, looking at the biology of chronic pain in more detail.” The study “found that the affected genes were overwhelmingly associated with brain tissue and nerve communication, rather than tissues where people typically experience the pain, such as joint cartilage or muscles.”

Studies point to possible biomarkers which could help detect CTE in living patients

The New York Times (11/19, Jacobs) reports researchers “believe they are one step closer to developing a blood test that could diagnose” chronic traumatic encephalopathy (CTE), “a degenerative and incurable brain disease often seen in football players, and which causes memory loss, dementia and troubling changes in behavior.” Two studies, published in JAMA over the past week, “describe two related biomarkers that are associated with abnormal collections of tau, the protein that helps keep nerve cells functioning properly.” The first study “identified a protein associated with CTE that is also found in patients with Alzheimer’s disease,” while the second study “found elevated levels of” related protein eMTBR-tau “in samples from nearly two dozen former football players who had donated blood before their death. Patients with more advanced CTE, the study found, had higher levels of the protein.”


AMA Morning Rounds news coverage is developed in affiliation with Bulletin Healthcare LLC. Subscribe to Morning Rounds Daily.

FEATURED STORIES

Man power walking or jogging, with dumbbells

New changes expand diabetes-prevention for more Medicare patients

| 3 Min Read
Three healthcare workers in discussion

AMA Joy in Medicine points the way to better care

| 5 Min Read
Doctors hold up magnifying glasses over a giant pancreas

Beyond watch and wait: Taking aim at pancreatic cysts

| 7 Min Read
Philip Kuriakose, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about microplastics

| 8 Min Read